Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Current Medicinal Chemistry|July 22, 2014
Nose-to-brain drug delivery by nanoparticles in the treatment of neurological disordersWei-Yi Ong, Suku-Maran Shalini, Luca Costantino
Journal of Medicinal Chemistry|November 24, 2005
Mono- or diphenylpyridazines connected to N-(2,4-difluorophenyl)-N'-heptylurea as acyl-CoA:cholesterol acyltransferase inhibitorsArianna Gelain, Ilaria Bettinelli, Daniela Barlocco, et al.
Bioorganic & Medicinal Chemistry|March 12, 2002
Discovery of new inhibitors of aldose reductase from molecular docking and database screeningGiulio Rastelli, Anna Maria Ferrari, Luca Costantino, et al.
Bioorganic & Medicinal Chemistry|November 5, 2002
Nitrophenyl derivatives as aldose reductase inhibitorsLuca Costantino, Anna Maria Ferrari, Maria Cristina Gamberini, et al.
Journal of Medicinal Chemistry|February 21, 2008
Biphenyl versus phenylpyridazine derivatives: the role of the heterocycle in a series of acyl-CoA:cholesterol acyl transferase inhibitorsArianna Gelain, Daniela Barlocco, Byoung-Mog Kwon, et al.
Bioorganic & Medicinal Chemistry|March 5, 2003
ortho-Halogen naphthaleins as specific inhibitors of Lactobacillus casei thymidylate synthase. Conformational properties and biological activityStefano Ghelli, Marcella Rinaldi, Daniela Barlocco, et al.
Biochimica Et Biophysica Acta|June 27, 2002
Structure-based studies on species-specific inhibition of thymidylate synthaseM Paola Costi, Donatella Tondi, Marcella Rinaldi, et al.
Journal of Medicinal Chemistry|October 1, 2004
Soft docking and multiple receptor conformations in virtual screeningAnna Maria Ferrari, Binqing Q Wei, Luca Costantino, et al.
Expert Opinion on Drug Delivery|February 6, 2008
Polymeric nanoparticles for the drug delivery to the central nervous systemGiovanni Tosi, Luca Costantino, Barbara Ruozi, et al.
Pageof 8